STANÍK, Michal, Jan DOLEŽEL, Daniel MACÍK, Antonín KRPENSKÝ and Radek LAKOMÝ. Primary adenocarcinoma of the epididymis: the therapeutic role of retroperitoneal lymphadenectomy. INTERNATIONAL UROLOGY AND NEPHROLOGY. DORDRECHT: SPRINGER, 2012, vol. 44, No 4, p. 1049-1053. ISSN 0301-1623. Available from: https://dx.doi.org/10.1007/s11255-012-0149-5.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Primary adenocarcinoma of the epididymis: the therapeutic role of retroperitoneal lymphadenectomy
Authors STANÍK, Michal, Jan DOLEŽEL, Daniel MACÍK, Antonín KRPENSKÝ and Radek LAKOMÝ.
Edition INTERNATIONAL UROLOGY AND NEPHROLOGY, DORDRECHT, SPRINGER, 2012, 0301-1623.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.325
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1007/s11255-012-0149-5
UT WoS 000306683200009
Keywords in English Adenocarcinoma; Epididymis; Therapy; Retroperitoneal lymphadenectomy
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 23/4/2014 14:26.
Abstract
This case report describes a rare case of adenocarcinoma of the epididymis and the role of locoregional surgery in the therapeutic algorithm. We report a case of primary adenocarcinoma of the epididymis in a 61-year-old man who was primarily examined for nodular enlargement of the head of the epididymis. Retroperitoneal lymphadenectomy which the patient underwent after radical orchiectomy revealed lymph node metastases, subsequently he received adjuvant chemotherapy. The patient remains free of disease for 20 months after surgery. Primary adenocarcinoma of epididymis is a rare finding with an unfavorable prognosis in higher stages as it responds poorly to radiotherapy and chemotherapy. Our case report confirms the importance of retroperitoneal lymphadenectomy in patients with local or locoregional disease. It may be curative even in case of proven lymphadenopathy and should be performed in all patients without distant metastases.
PrintDisplayed: 24/5/2024 09:46